? Neuroblastoma drug resistance

NAME Dr. Daniel Carter
CANCER TYPE Neuroblastoma
INSTITUTION University of New South Wales
STATE New South Wales
GRANT TYPE $50,000

A novel single-cell transcriptomics drug screen to reveal mechanisms of neuroblastoma drug resistance

This research aims to create an invaluable dataset that applies novel technology to identify mechanisms of drug resistance at the single-cell level, so that we can begin to conceive new therapeutic opportunities to overcome intratumoural heterogeneity.

Best Replica Watches perfect-clones.com Rolex Replica Watches Replica Watches Audemars Piguet Replica Watches Richard Mille Replica